VALENTINI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.246
EU - Europa 1.684
AS - Asia 1.085
AF - Africa 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.027
Nazione #
US - Stati Uniti d'America 2.235
CN - Cina 1.034
IE - Irlanda 519
UA - Ucraina 328
FI - Finlandia 255
DE - Germania 164
SE - Svezia 135
IT - Italia 108
GB - Regno Unito 79
FR - Francia 44
BE - Belgio 27
SG - Singapore 24
CA - Canada 11
NL - Olanda 8
IN - India 7
IR - Iran 6
JP - Giappone 6
CZ - Repubblica Ceca 4
MU - Mauritius 4
RU - Federazione Russa 3
AR - Argentina 2
AT - Austria 2
CL - Cile 2
EG - Egitto 2
HK - Hong Kong 2
MD - Moldavia 2
PK - Pakistan 2
RO - Romania 2
AU - Australia 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
LV - Lettonia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 5.027
Città #
Dublin 519
Chandler 505
Jacksonville 372
Nanjing 269
Ann Arbor 152
Boardman 146
Beijing 145
Nanchang 130
Ashburn 125
Wilmington 104
Helsinki 91
Lawrence 85
Medford 85
Princeton 85
Shenyang 74
Hebei 70
Changsha 68
New York 67
Jiaxing 61
Hangzhou 59
Tianjin 58
Shanghai 44
Woodbridge 39
Milan 38
Brussels 27
Verona 25
Norwalk 15
Dearborn 14
Falls Church 14
Pavia 12
Auburn Hills 11
Singapore 11
Des Moines 9
Fairfield 9
Tappahannock 9
Jinan 8
Piscataway 8
Kunming 7
Los Angeles 7
Seattle 7
Taizhou 7
Toronto 7
Chicago 6
Ningbo 6
Kiel 5
Tokyo 5
Brno 4
Munich 4
Sacramento 4
San Genesio ed Uniti 4
Zhengzhou 4
Andover 3
Birmingham 3
Fuzhou 3
Groningen 3
Zanjan 3
Castenaso 2
Changchun 2
Chisinau 2
Costa Mesa 2
Haikou 2
Houston 2
Islamabad 2
Leawood 2
London 2
Monmouth Junction 2
Paderno Dugnano 2
Vienna 2
Amman 1
Andrushivka 1
Baghdad 1
Bengaluru 1
Buenos Aires 1
Cambridge 1
Charlottetown 1
Chorley 1
Dallas 1
Delhi 1
Faenza 1
Falkenstein 1
Focsani 1
Fontana 1
Guangzhou 1
Hefei 1
Hyderabad 1
Madrid 1
Melbourne 1
Mumbai 1
Muskego 1
Natchez 1
New Westminster 1
Newbury Park 1
Nürnberg 1
Orange 1
Pedrengo 1
Phoenix 1
Pune 1
Qingdao 1
Raleigh 1
Redmond 1
Totale 3.711
Nome #
The prion-like doppel protein is soluble in astrocytic tumor 91
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 85
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 84
Expanding targets for a metabolic therapy of cancer: L-asparaginase 84
Letter to the editor regarding Shibayama et al.: Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase. 81
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli: ligands promoted conformational changes 81
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 81
Phosphoglycerate Kinase Deficiency: Characterization of the Wild-Type Enzyme and Three Pathological Variants Generated from C.140T>a, C.491A>T and C.959G>a Mutations 79
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 79
Influence of fibronectine on the fibrillogenesis of type I and type III collagen 79
Generation of Mutants of Helicobacter pylori L-Asparaginase 77
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 77
Two forms of pyruvate kinase in Escherichia coli. A comparison of chemical and molecular properties 74
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia 73
Pyruvate kinase deficiency: Biochemical characterization of two mutations causing inability of the enzyme to properly bind substrates 71
Absence of interaction between doppel and GFAP, Grb2, PrPC proteins in human tumor astrocytic cells 71
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 71
Aberrant Doppel Protein Expression in Human Astrocytic Tumors 70
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 70
Recombinant pyruvate kinase type I from Escherichia coli:overproduction and revised C-terminus of the polypeptide 69
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 69
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 67
A simple procedure for the purification of neutral salt soluble type I collagene from skin. 67
Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia 66
Purification and molecular properties of the AMP-activated pyruvate kinase from Escherichia coli. 65
Molecular cloning and characterisation of Helicobacter pylori L-asparaginase 65
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. Natures of bonds involved in the allosteric mecchanism. 64
Affinity labelling of the catalytic and allosteric ATP binding sites on pyruvate kinase type I from Escherichia coli. 64
Biochemical signatures of doppel (Dpl) protein in human glioblastoma to support prediction in tumor malignancy 64
Helicobacter pylori: from gene to Diagnostic Tool 64
Crystallization and preliminary X-ray analysis of pyruvate kinase type I from Escherichia coli. 64
A comparative study on liver ornithine carbamoyl transferase from a marine mammal Stenella and a elasmobranch Sphyrna zygaena. 63
An essential lysine in the substrate-binding of ornithine carbamoyl transferase 62
AMP- and fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. 62
Helicobacter pylori L-asparaginase: from Gene to Diagnostic Tool 62
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition 62
SELECTION OF MICROFUNGI WITH HIGH LIPOLYTIC ACTIVITYAND THEIR LIPASE CHARACTERIZATION 61
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 61
Pyrimidine 5' Nucleotidase Deficiency: Clinical and Molecular Characterization of Two New Italian Patients 61
Reactivity of the fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli with pyridoxal 5’-phosphate 60
Premio Ricercatissimi 2008 60
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 60
Human erythrocyte pyruvate kinase:characterization of the recombinant enzyme and a mutant form(R510Q))causing nonspherocytic hemolytic anemia. 60
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 59
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 58
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 58
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5-Nucleotidase Causing Hereditary Hemolytic Anemia. 58
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 58
EXPRESSION AND CHARACTERIZATION OF THE BOVINE PRION DOPPEL 57
Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations 57
Bacterial pyruvate kinases have a shorter N-terminal domain 57
Characterization of a pyrimidine 5'-nucleotidase mutant form (G214R) causing hereditary hemolytic anemia. 57
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 57
Molecular and functional characterization of a lethal variant of pyruvate kinase deficiency 56
The allosteric regulation of pyruvate kinase 56
PYRUVATE KINASE DEFICIENCY: MOLECULAR AND FUNCTIONAL CHARACTERISATION OF A LETHAL VARIANT 56
The allosteric regulation of pyruvate kinase. 56
Functional and structural characterization of ovine ornithine transcarbamoylase 55
Molecular Insights on Pathogenic Effects of MutationsCausing Phosphoglycerate Kinase Deficiency 55
Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency 55
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview 54
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 53
L-ASPARAGINASE FROM HELICOBACTER PYLORI 52
Red cell pyruvate kinase deficiency: molecular and clinical aspects 52
Pyruvate kinase deficiency : The genotype-phenotype association 52
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene 52
Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography. 51
Two new mutations of the P5'N-1 gene found in Italian patients with hereditary hemolytic anemia: the molecular basis of the red cell enzyme disorder. 51
Investigating the Molecular Bases of the Phosphoglycerate Kinase Deficiency: Characterization ofG158V, R206P, V266M and D285V Pathological Variants. 51
Aeroplane shaped crystal of a mutant ofHelicobacter pylori L-asparaginase. 51
Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. 50
Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia 49
Protein Stability, Folding and Misfolding in Human PGK1 Deficiency 48
Molecular Basis of Hemolytic Anemia: First Biochemical Characterization of Wild-Type and N190S Mutant Human Erythrocyte Pyrimidine 5'-Nucleotidase. 48
Functional Analysis of Two Mutants of Pyrimidine 5’ Nucleotidase Causing Nonspherocytic Hemolytic Anemia 47
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia 44
Monitoring Inosine monophosphate dehydrogenase (IMPDH) in kidney transplant recipients 44
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 43
Molecular Cloning and Characterisation of Helicobacter Pylori L-Asparaginase: A Cytotoxic Factor with Potential Biomedical Applications 39
Helicobacter pylori L-asparaginase: A promising chemotherapeutic agent 38
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 34
PHOSPHOGLYCERATE KINASE DEFICIENCY: FUNCTIONAL PROPERTIES OF THE L89P, K191DEL, C316R AND A354P PATHOLOGICAL VARIANTS 34
The interplay between protein stability and folding co-operativity in loss-of-function genetic disease: The case of human PGK1 deficiency. 30
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy 29
Protein stability, folding and misfolding in human PGK1 deficiency 12
Totale 5.073
Categoria #
all - tutte 17.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020448 0 0 7 63 4 65 18 79 16 109 81 6
2020/2021605 78 46 25 63 4 79 8 87 19 91 86 19
2021/2022450 6 7 9 6 26 17 15 32 32 20 51 229
2022/20231.411 124 122 9 128 157 155 1 64 594 8 32 17
2023/2024516 121 70 6 43 50 141 7 32 0 12 20 14
2024/2025125 28 97 0 0 0 0 0 0 0 0 0 0
Totale 5.073